Quarterly Result23 Jan 2026, 03:05 pm
Innova Captab Ltd Reports 42.3% YoY Revenue Growth and 39.6% EBIDTA Growth in Q3 FY26
AI Summary
Innova Captab Ltd, a leading pharmaceutical company, has reported strong financial results for the quarter and nine months ended 31st December 2025. The company's revenue from operations for Q3 FY26 stood at ₹ 450.3 crores, representing a 42.3% YoY growth. The EBIDTA for the quarter was ₹ 71.1 crores, reflecting a 39.6% YoY growth. The company's 9M FY26 revenue from operations cumulated to ₹ 1182.2 crores, marking a 27.3% YoY growth. The EBIDTA for 9M FY26 stood at ₹ 183.7 crores, representing a 25% YoY growth.
Key Highlights
- Revenue from Operations for Q3 FY26 stood at ₹ 450.3 crores, up by 42% YoY
- EBIDTA for Q3 FY26 was ₹ 71.1 crores, up by 39.6% YoY
- 9M FY26 revenue from operations cumulated to ₹ 1182.2 crores, up by 27.3% YoY
- EBIDTA for 9M FY26 stood at ₹ 183.7 crores, up by 25% YoY
- Company received Certificate of GMP Compliance from UK-MHRA and PIC/s for its manufacturing facilities